1. Folic acid attenuates homocysteine and enhances antioxidative capacity in atherosclerotic rats
   Shanshan Cui et al, 2017, Appl. Physiol. Nutr. Metab. CrossRef
2. Effects of Chronic and Intermittent Calorie Restriction on Adropin Levels in Breast Cancer
   Bilge G. Tuna et al, 2017, Nutrition and Cancer CrossRef
3. Adropin Contributes to Anti-Atherosclerosis by Suppressing Monocyte-Endothelial Cell Adhesion and Smooth Muscle Cell Proliferation
   Kengo Sato et al, 2018, IJMS CrossRef
4. Inhibitory effect of recombinant human CXCL8(3-72)K11R/G31P on atherosclerotic plaques in a mouse model of atherosclerosis
   Yuanhua Qin et al, 2019, Immunopharmacology and Immunotoxicology CrossRef
5. Are adropin, apelin, elabela, asprosin and betatrophin biomarkers for chronic hepatitis and staging of fibrosis?
   G. Eser Karlidag et al, 2020, Biotechnic & Histochemistry CrossRef
6. A Review of Adropin as the Medium of Dialogue between Energy Regulation and Immune Regulation
   Shuyu Zhang et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
7. Association of polymorphisms of preptin, irisin and adropin genes with susceptibility to coronary artery disease and hypertension
   Haidong Wang et al, 2020, Medicine CrossRef
8. Amelioration of cognitive deficits by Spirulina platensis in L-methionine-induced rat model of vascular dementia
   Pian Wang et al, 2020, Phcog Mag CrossRef
9. Adropin as a potential mediator of the metabolic system‐autonomic nervous system‐chronobiology axis: Implementing a personalized signature‐based platform for chronotherapy
   Yotam Kolben et al, 2020, Obesity Reviews CrossRef
10. ST Segment Yükselmeli Miyokard İnfarktüsü Hastalarında Koroner Arter Hastalığının Ciddiyeti ile Serum Adropin Seviyesi Arasındaki İlişkinin Değerlendirilmesi
    Mustafa ÖZTÜRK et al, 2020 CrossRef
11. The Evaluation of Ischemia Modified Albumin and Adropin Levels in Patients with Pulmonary Embolism
    Sami ERDEM et al, 2021 CrossRef
12. New Peptides as Potential Players in the Crosstalk Between the Brain and Obesity, Metabolic and Cardiovascular Diseases
    Magdalena Czerwińska et al, 2021, Front. Physiol. CrossRef
13. Adropin Serum Levels in Patients with Primary Sjögren’s Syndrome
    Marijana Janković Danolić et al, 2021, Biomolecules CrossRef
14. Liraglutide blocks the proliferation, migration and phenotypic switching of Homocysteine (Hcy)-induced vascular smooth muscle cells (VSMCs) by suppressing proprotein convertase subtilisin kexin9 (PCSK9)/ low-density lipoprotein receptor (LDLR)
    Jingquan Ji et al, 2021, Bioengineered CrossRef
15. The association between serum adropin and carotid atherosclerosis in patients with type 2 diabetes mellitus: a cross‑sectional study
    Wen Wei et al, 2022, Diabetol Metab Syndr CrossRef
16. Adropin’s Role in Energy Homeostasis and Metabolic Disorders
    Ifrah Ismail Ali et al, 2022, IJMS CrossRef
17. Using Bayesian network model with MMHC algorithm to detect risk factors for stroke
    Wenzhu Song et al, 2022, MBE CrossRef
18. Serum Adropin Level in the Early Period of ST-Elevation Myocardial Infarction and Its Relationship With Cobalamin and Folic Acid.
    Mehmet Şahin Adıyaman et al, 2022, Cureus CrossRef
19. Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation
    Vladimir Khavinson et al, 2022, Cells CrossRef
20. A novel interleukin-2-based fusion molecule, HCW9302, differentially promotes regulatory T cell expansion to treat atherosclerosis in mice
    Xiaoyun Zhu et al, 2023, Front. Immunol. CrossRef
21. Using Bayesian networks with Tabu-search algorithm to explore risk factors for hyperhomocysteinemia
    Wenzhu Song et al, 2023, Sci Rep CrossRef
22. Association Between Serum Adropin Level and Cardiac Target Organ Damages in Patients Undergoing Invasive Coronary Angiography
    Hack-Lyoung Kim et al, 2023, Cardiometab Syndr J CrossRef
23. Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines
    Alexander A. Berezin et al, 2023, Antioxidants CrossRef
24. Feeding-induced hepatokines and crosstalk with multi-organ: A novel therapeutic target for Type 2 diabetes
    Rong-Bin Chen et al, 2023, Front. Endocrinol. CrossRef
25. Circulating levels of adropin and diabetes: a systematic review and meta-analysis of observational studies
    Sepideh Soltani et al, 2023, BMC Endocr Disord CrossRef
26. Adropin – A new player in energy regulation predicts long-term prognosis of patients with acute myocardial infarction
    Xiansong Chang et al, 2023, Heliyon CrossRef
27. Relation between homocysteine-to-adropin ratio and severity of coronary artery disease
    Ola Hassan Abd Elaziz et al, 2024, ELECTRON J GEN MED CrossRef
28. Evaluation of Adropin Levels in Cardiovascular Disease
    Mutlak M. Taha et al, 2024, JPDMHD CrossRef
29. Dietary intake of methyl donor nutrients in relation to metabolic health status, serum levels of brain-derived neurotrophic factor and adropin
    Donya Poursalehi et al, 2024, Clinical Nutrition CrossRef
30. Effect of nano-curcumin supplementation on angina status, and traditional and novel cardiovascular risk factors in overweight or obese patients with coronary slow flow phenomenon: a randomized double-blind placebo-controlled clinical trial
    Mahsa Rezaei et al, 2024, BMC Nutr CrossRef
31. Unveiling the multifaceted role of adropin in various diseases (Review)
    Ling Chen et al, 2024, Int J Mol Med CrossRef
32. Advances in Research on Adropin: Potential Implications for Clinical Diagnosis and Possible Treatment – A Mini-Review
    Agnieszka Berdowska et al, 2024, CP CrossRef